Table 3. Estimated healthcare costs and consequences.
| Intervention | Total costs
(£; 2021) |
Total QALYs | Incremental cost per
QALY gained |
|---|---|---|---|
| Deterministic base case analysis | |||
| CYP2C19 testing | £59,059 | 7.409 | Not applicable
CYP2C19 testing dominant |
| No testing | £59,517 | 7.302 | |
| Probabilistic sensitivity analysis | |||
| CYP2C19 testing | £58,769 | 7.363 | Not applicable
CYP2C19 testing dominant |
| No testing | £58,893 | 7.271 | |